Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Acetylon Pharmaceuticals to utilise additional funding in multiple myeloma drug development

Acetylon Pharmaceuticals to utilise additional funding in multiple myeloma drug development

Proteostasis Therapeutics enters into exclusive license agreement with New York University

Proteostasis Therapeutics enters into exclusive license agreement with New York University

Phase 1 clinical trial of SIRT1 inhibitor for the treatment of Huntington’s Disease commenced

Phase 1 clinical trial of SIRT1 inhibitor for the treatment of Huntington’s Disease commenced

Sundia MediTech Company recognized as technically-advanced service enterprise in Shanghai

Sundia MediTech Company recognized as technically-advanced service enterprise in Shanghai

Educational sessions and special workshops highlight advancements in molecular imaging

Educational sessions and special workshops highlight advancements in molecular imaging

Researchers identify new approach to eliminate side effects of drugs

Researchers identify new approach to eliminate side effects of drugs

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Alnylam Pharmaceuticals receives payment from Roche to initiate pre-IND studies for RNAi therapeutics

Ensemble Discovery initiates strategic alliance with Pfizer

Ensemble Discovery initiates strategic alliance with Pfizer

Findings open up significant possibilities for developing micro-screening devices for drug discovery

Findings open up significant possibilities for developing micro-screening devices for drug discovery

Biotime ships six ACTCellerate progenitor cell lines to Millipore

Biotime ships six ACTCellerate progenitor cell lines to Millipore

CBI signs definitive share purchase agreement to acquire  GL Biochem

CBI signs definitive share purchase agreement to acquire GL Biochem

DMET genotyping platform screens for 1256 genetic variations in 170 genes

DMET genotyping platform screens for 1256 genetic variations in 170 genes

Emerald BioStructures engineers new allosteric small molecule modulators of the PDE4 enzyme

Emerald BioStructures engineers new allosteric small molecule modulators of the PDE4 enzyme

Publication validates company's structure-based approach for addressing undruggable targets

Publication validates company's structure-based approach for addressing undruggable targets

MDRNA closes $1M bridge loan

MDRNA closes $1M bridge loan

New compound may halt drug-resistant lung cancer

New compound may halt drug-resistant lung cancer

Ligand Pharmaceuticals acquires Neurogen

Ligand Pharmaceuticals acquires Neurogen

Viron Therapeutics' three drug candidates granted U.S. patents

Viron Therapeutics' three drug candidates granted U.S. patents

WuXi PharmaTech announces winners of third Life Science and Chemistry Awards

WuXi PharmaTech announces winners of third Life Science and Chemistry Awards

CombinatoRx and Neuromed Pharmaceuticals complete merger agreement

CombinatoRx and Neuromed Pharmaceuticals complete merger agreement

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.